Ator-vastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial - Sillesen, H; Amarenco, P; Hennerici, MG (Stroke, 2008)
et al.